| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Search the digital library catalog Help

Query: search in
search in
search in
search in
* old and bologna study programme

Options:
  Reset


1 - 2 / 2
First pagePrevious page1Next pageLast page
1.
Clinical pharmacy services in mental health in Europe : a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health
Matej Štuhec, Martina Hahn, I. Taskova, I. Bayraktar, I. Fitzgerald, L. Molitschnig, A. Tatarević, N. Lindner, L. Agnoletto, Filipa Alves da Costa, 2023, review article

Abstract: A large proportion of the world's disease burden is attributable to mental illnesses. Although effective interventions are available, many patients still have limited access to evidence-based treatments. Aside from access, treatment gaps, including inappropriate medication selection and monitoring, are also routinely recognised. Mental health clinical pharmacists can help address these gaps and enable patients to receive optimised pharmaceutical care, particularly appropriate medication selection and monitoring. The European Society of Clinical Pharmacy (ESCP) Special Interest Group on Mental Health was established to improve standardised service provision in mental health settings across Europe. The Special Interest Group identified significant barriers (predominantly associated with reimbursement and position within the multidisciplinary team) to effective pharmaceutical care amongst those with mental illnesses. This commentary presents recommendations to address these gaps through improved mental health clinical pharmacy service provision.
Keywords: clinical pharmacist interventions, clinical pharmacy in mental health, European society of clinical pharmacy, mental illnesses and pharmacy, pharmaceutical services in mental health, polypharmacy and clinical pharmacy, psychotropics and clinical pharmacy
Published in DKUM: 15.04.2024; Views: 108; Downloads: 3
.pdf Full text (404,08 KB)
This document has many files! More...

2.
Medical-legal aspects of confidentiality in the field of pharmaceutical health care
Hajrija Mujovic, 2017, original scientific article

Abstract: The field of pharmaceutical health care is becoming increasingly established. Modernly, pharmacists learn more from patients about their prescriptions and other very personal, sensitive information. However, having access to an ever-increasing amount of sensitive, personal information raises serious issues pertaining to patient secrets and confidentiality. The term professional secrecy (hereinafter confidentiality) as well as any other form of discretion connected with a professional activity is construed broadly. However, the precise scope of confidentiality is not strictly defined in legislation. Obligation of professional secrecy has been diminished partly due to the general progress in a society and the progress of medical professions. The development of the protection of human rights is a continuous process.
Keywords: pharmaceutical services, privacy, confidentiality, professional secrecy, liability
Published in DKUM: 02.08.2018; Views: 930; Downloads: 58
.pdf Full text (372,26 KB)
This document has many files! More...

Search done in 0.83 sec.
Back to top
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica